Ophthalmic Education:
Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist: Appendix 1: Macular Photocoagulation Study (MPS)
More on Ophthalmic Education:
Educational Resources:
ICO Educational Programs:
- Overview of ICO Education
- Resident and Specialist Education
- Ophthalmic Continuing Education
- ICO Continuing Education Requirements
- Medical Student Education
- Allied Ophthalmic Personnel Training
- International Congress of Ophthalmology
- ICO Basic and Clinical Assessments
- IFOS/ICO International Fellowship
- ICO International Clinical Guidelines
On this page:
Recommended Reading
(No authors listed). Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1997; 115: 741-747
(No authors listed). Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112: 500-509
(No authors listed). Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol 1993; 111: 1189-1199
(No authors listed). Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1993; 111: 1200-1209
(No authors listed). Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1109-1114
(No authors listed). Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108: 816-824
(No authors listed). Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108: 825-831
Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108: 1442-1447
Chamberlin JA, Bressler NM, Bressler SB et al. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group. Ophthalmology 1989; 96: 1526-1534
No authors listed). Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1987; 105: 1499-1507
(No authors listed). Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group. Arch Ophthalmol 1986; 104: 503-512
(No authors listed). Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1986; 104: 694-701
(No authors listed). Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1983; 101: 1347-1357
(No authors listed). Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial. Arch Ophthalmol 1983; 101: 1358-1361
(No authors listed). Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982; 100: 912-918
Zimmer-Galler IE, Bressler NM, Bressler SB. Treatment of choroidal neovascularization: updated information from recent macular photocoagulation study group reports. Int Ophthalmol Clin 1995; 35: 37-57
Additional Background Reading
(No authors listed). Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1996; 114: 400-412
(No authors listed). Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol 1996; 114: 677-688
(No authors listed). Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group. Arch Ophthalmol 1995; 113: 56-61
(No authors listed). The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol 1995; 113: 190-194
(No authors listed). Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112: 480-488
(No authors listed). Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112: 489-499
(No authors listed). Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group. Arch Ophthalmol 1994; 112: 1176-1184
Birch DG, Anderson JL, Fish GE, Jost BF. Pattern-reversal electroretinographic follow-up of laser photocoagulation for subfoveal neovascular lesions in age-related macular degeneration. Am J Ophthalmol 1993; 116: 148-155
Fine SL. The case for treating subfoveal neovascularization in patients with age-related macular degeneration, in Franklin RM (ed): Retina and Vitreous. Proceedings of the Symposium on Retina and Vitreous, New Orleans Academy of Ophthalmology, New York, Kugler Publications: 1993; 29-30
Birch DG, Anderson AL, Fish GE, Jost BF. Pattern-reversal electroretinographic acuity in untreated eyes with subfoveal neovascular membranes. Invest Ophthalmol Vis Sci 1992; 33: 2097-2104
Orr PR, Blackhurst DW, Hawkins BS. Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial. The Macular Photocoagulation Study Group. Control Clin Trials 1992; 13: 40-49
Bressler NM, Bressler SB, Alexander J et al. Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. Arch Ophthalmol 1991; 109: 211-215
(No authors listed). Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1220-1231
(No authors listed). Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1232-1241
(No authors listed). Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1242-1257
Hawkins BS, Prior MJ, Fisher MR, Blackhurst DW. Relationship between rate of patient enrollment and quality of clinical center performance in two multicenter trials in ophthalmology. Control Clin Trials 1990; 11:374-394
(No authors listed). Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108: 832-837
Blackhurst DW, Maguire MG. Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group. Retina 1989; 9: 163-169
(No authors listed). Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group. Arch Ophthalmol 1989; 107: 344-352
Hillis A, Maguire M, Hawkins BS, Newhouse MM. The Markov process as a general method for nonparametric analysis of right-censored medical data. J Chronic Dis 1986; 39: 595-604
Fine SL. Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology 1985; 92: 603-609
(No authors listed). Changing the protocol: a case report from the Macular Photocoagulation Study. Macular Photocoagulation Study Group. Control Clin Trials 1984; 5: 203-216
Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 1999; 77: 422-425
(No authors listed). Age-related macular degeneration. The Macular Photocoagulation Study. Am J Ophthalmol 1984; 98: 376-377
Freund KB. Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993; 115: 786-791
Jampol LM. Hypertension and visual outcome in the macular photocoagulation study. Arch Ophthalmol 1991; 109: 789-790
Jost BF, Alexander MF, Maguire MG et al. Laser treatment for choroidal neovascularization outside randomized clinical trials. Arch Ophthalmol 1988; 106: 357-361
Fine SL. Macular photocoagulation study. Arch Ophthalmol 1980; 98: 832
Fine SL, Hawkins B, Maguire M. Macular photocoagulation study. Arch Ophthalmol 1984; 102: 1583
Jampol LM, Tielsch J. Race, macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 1992; 110: 1699-1700
Moisseiev J, Alhalel A, Masuri R, Treister G. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995; 113: 185-189
Beatty S, Au Eong KG, McLeod D, Bishop PN. Photocoagulation of subfoveal choroidal neovascular membranes in age related macular degeneration: the impact of the macular photocoagulation study in the United Kingdom and Republic of Ireland. Br J Ophthalmol 1999; 83: 1103-1104
Custis PH, Bressler SB, Bressler NM. Laser management of subfoveal choroidal neovascularization in age-related macular degeneration. Curr Opin Ophthalmol 1993; 4: 7-18
Dyer DS, Bressler SB, Bressler NM. The role of laser wavelength in the treatment of vitreoretinal diseases. Curr Opin Ophthalmol 1994; 5: 35-43
Bergink GJ, Deutman AF, van den Broek JF, van Daal WA,. van der Maazen RW. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study.Graefes Arch Clin Exp Ophthalmol 1994; 232: 591-598
Gelfand YA, Linn S, Miller B. The application of the macular photocoagulation study eligibility criteria for laser treatment in age-related macular degeneration. Ophthalmic Surg Lasers 1997; 28: 823-827
Spaide RF. Guyer DR. McCormick B et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998; 105: 24-30
Ormerod LD, Puklin JE, Frank RN. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology 1994; 101: 1201-1210
Avvad FK, Duker JS, Reichel E, Margolis TI, Puliafito CA. The digital indocyanine green videoangiography characteristics of well-defined choroidal neovascularization. Ophthalmology 1995; 102: 401-405
Yannuzzi LA. A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Data revisited. Arch Ophthalmol 1994; 112: 462-464
Tiedeman JS. Treatment of subfoveal choroidal neovascularization. Arch Ophthalmol 1995; 113: 137-138
Hawkins WR. Visual prognosis of eyes with submacular choroidal neovascularization. Arch Ophthalmol 1994; 112: 874-875
Fine SL, Hawkins BS, Maguire MG. Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1991; 109: 614-615
Tornambe PE, Poliner LS. Partial ablation of neovascular membranes involving the fovea. Arch Ophthalmol 1989; 107: 955-956
Wolfe JA, Horton MB, McAteer MB, Szuter CF, Clayton T. Race, macular degeneration, and diabetic maculopathy. Arch Ophthalmol 1993; 111: 1603-1604
Chakravarthy U, Hart P, Finger P. External beam radiation therapy for CNV. Ophthalmology 1998; 105: 1790-1791; author reply 1791-1792
Beaumont P, Chang A. External beam radiation therapy for CNV.Ophthalmology 1998; 105: 1792-1793; author reply 1793-1794
Schachat AP. Management of subfoveal choroidal neovascularization. Arch Ophthalmol 1991; 109: 1217-1218
Next: Appendix 1: Age-Related Eye Disease Study (AREDS)
Also see: Table of Contents of the Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist
You are here: Home > Ophthalmic Education > Resident and Specialist Education > Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist > Appendix 1: Macular Photocoagulation Study (MPS)